Diabetologie und Stoffwechsel 2018; 13(S 01): S19
DOI: 10.1055/s-0038-1641809
DOI: 10.1055/s-0038-1641809
Poster
Typ-2-Diabetes – Pathophysiologie I
TGFß regulates metabolism of human skeletal muscle cells by miRNAs
S Höckele
1
Helmholtz Zentrum München, Institute of Experimental Genetics, Neuherberg, Germany
2
German Center for Diabetes Research (DZD), Neuherberg, Germany
,
P Huypens
1
Helmholtz Zentrum München, Institute of Experimental Genetics, Neuherberg, Germany
,
C Hoffmann
3
University Hospital Tübingen, Division of Endocrinology, Diabetology, Angiology, Nephrology, Pathobiochemistry and Clinical Chemistry, Department of Internal Medicine IV, Tübingen, Germany
,
T Jeske
4
Helmholtz Zentrum München, Institute of Bioinformatics and Systems Biology, Neuherberg, Germany
5
Dr. Hauner Children's Hospital, Ludwig-Maximilians-Universität München, Department of Pediatrics, München, Germany
,
M Hastreiter
6
Helmholtz Zentrum München, Institute of Computational Biology, Neuherberg, Germany
7
Technische Universität München, Lehrstuhl für Genomorientierte Bioinformatik, Freising, Germany
,
A Böhm
2
German Center for Diabetes Research (DZD), Neuherberg, Germany
3
University Hospital Tübingen, Division of Endocrinology, Diabetology, Angiology, Nephrology, Pathobiochemistry and Clinical Chemistry, Department of Internal Medicine IV, Tübingen, Germany
8
University of Tübingen, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München, Tübingen, Germany
,
J Beckers
1
Helmholtz Zentrum München, Institute of Experimental Genetics, Neuherberg, Germany
2
German Center for Diabetes Research (DZD), Neuherberg, Germany
9
Technische Universität München, Institute of Experimental Genetics, Freising, Germany
,
HU Häring
2
German Center for Diabetes Research (DZD), Neuherberg, Germany
3
University Hospital Tübingen, Division of Endocrinology, Diabetology, Angiology, Nephrology, Pathobiochemistry and Clinical Chemistry, Department of Internal Medicine IV, Tübingen, Germany
8
University of Tübingen, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München, Tübingen, Germany
,
M Hrabe de Angelis
1
Helmholtz Zentrum München, Institute of Experimental Genetics, Neuherberg, Germany
2
German Center for Diabetes Research (DZD), Neuherberg, Germany
9
Technische Universität München, Institute of Experimental Genetics, Freising, Germany
,
C Weigert
2
German Center for Diabetes Research (DZD), Neuherberg, Germany
3
University Hospital Tübingen, Division of Endocrinology, Diabetology, Angiology, Nephrology, Pathobiochemistry and Clinical Chemistry, Department of Internal Medicine IV, Tübingen, Germany
8
University of Tübingen, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München, Tübingen, Germany
› Author Affiliations